Literature DB >> 16960018

Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton.

Aviva Levine Fridman1, Lin Tang, Olga I Kulaeva, Bin Ye, Qunfang Li, Fatimah Nahhas, Paul C Roberts, Susan J Land, Judith Abrams, Michael A Tainsky.   

Abstract

Abrogation of cellular senescence, resulting in immortalization, is a necessary step in the tumorigenic transformation of a cell. Four independent, spontaneously immortalized Li-Fraumeni syndrome (LFS) cell lines were used to analyze the gene expression changes that may have given these cell lines the growth advantage required to become immortal. A cellular senescence-like phenotype can be induced in immortal LFS cells by treating them with the DNA methyltransferase (DNMT) inhibitor 5-aza-deoxycytidine. We hypothesized, therefore, that genes epigenetically silenced by promoter methylation are potentially key regulators of senescence. We used microarrays to compare the epigenetic gene expression profiles of precrisis LFS cells with immortal LFS cells. Gene ontology analysis of the expression data revealed a statistically significant contribution of interferon pathway, cell cycle, and cytoskeletal genes in the process of immortalization. The identification of the genes and pathways regulating immortalization will lead to a better understanding of cellular immortalization and molecular targets in cancer and aging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960018     DOI: 10.1093/gerona/61.9.879

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  18 in total

1.  Higher miRNA tolerance in immortal Li-Fraumeni fibroblasts with abrogated interferon signaling pathway.

Authors:  Qunfang Li; Michael A Tainsky
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

2.  Unstable genomes elevate transcriptome dynamics.

Authors:  Joshua B Stevens; Guo Liu; Batoul Y Abdallah; Steven D Horne; Karen J Ye; Steven W Bremer; Christine J Ye; Stephen A Krawetz; Henry H Heng
Journal:  Int J Cancer       Date:  2014-05-01       Impact factor: 7.396

3.  Gene expression profiling of replicative and induced senescence.

Authors:  Maggie Purcell; Adele Kruger; Michael A Tainsky
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  CREG1 enhances p16(INK4a) -induced cellular senescence.

Authors:  Benchamart Moolmuang; Michael A Tainsky
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

Review 5.  Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity.

Authors:  Divaker Choubey; Xin Duan; Eric Dickerson; Larissa Ponomareva; Ravichandran Panchanathan; Hui Shen; Ratika Srivastava
Journal:  J Interferon Cytokine Res       Date:  2010-06       Impact factor: 2.607

6.  Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses.

Authors:  Patrick Paladino; Susan E Collins; Karen L Mossman
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

Review 7.  Senescence-messaging secretome: SMS-ing cellular stress.

Authors:  Thomas Kuilman; Daniel S Peeper
Journal:  Nat Rev Cancer       Date:  2009-01-09       Impact factor: 60.716

8.  Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts.

Authors:  Qunfang Li; Lin Tang; Paul Christopher Roberts; Janice M Kraniak; Aviva Levine Fridman; Olga I Kulaeva; Omid S Tehrani; Michael A Tainsky
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

Review 9.  Critical pathways in cellular senescence and immortalization revealed by gene expression profiling.

Authors:  A L Fridman; M A Tainsky
Journal:  Oncogene       Date:  2008-08-18       Impact factor: 9.867

10.  Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.

Authors:  Lynda Li Song; Larissa Ponomareva; Hui Shen; Xin Duan; Fatouma Alimirah; Divaker Choubey
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.